|
⚲
|
| Keyboard |
| Javitt Jonathan C
✚
|
|
|---|---|
| CIK # | 0001303782 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001303782] | |
| 4 | [0001303782] | |
| 5 | [0001303782] | |
| SC 13D | [0001303782] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Javitt Jonathan C | NRX Pharmaceuticals Inc | [2022-06-03] |
| Javitt Jonathan C | NRX Pharmaceuticals Inc | [2021-06-03] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| NRX Pharmaceuticals Inc | |
| Javitt Jonathan C |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2024-12-17 | Buy | 40,000 | $1.17 | 46,800 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2023-08-23 | Buy | 100,000 | $0.33 | 33,000 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2023-08-22 | Buy | 200,000 | $0.32 | 64,000 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock, par value $0.001 per share
|
2022-12-14 | Gift | 300,000 | $0.00 | |
|
NRX Pharmaceuticals Inc NRXP
Common Stock, par value $0.001 per share
|
2022-12-07 | Sell | 400,000 | $1.00 | 400,000 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2022-06-01 | Buy | 100,000 | $58.00 | 5,800,000 |
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2021-05-24 | Grant | 46,332 | ||
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2021-05-24 | Grant | 1,422,000 | ||
|
NRX Pharmaceuticals Inc NRXP
Common Stock
|
2021-05-24 | Grant | 13,348,997 |